Overview
WARNING: As this organisation lists one or more EP accredited lobbyists, it may not be probable that its lobbying costs are lower than €10,000.
Lobbying Costs
9,999€
Financial year: Jul 2015 - Jun 2016
Lobbyists (Full time equivalent)
0.25 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Global Alliance of Mental Illness Advocacy Networks (GAMIAN-Europe)
EU Transparency Register
50813891737-43 First registered on 22 May 2009
Goals / Remit
GAMIAN-Europe, a patient-driven pan-European organisation, seeks to represent the interests and inclusion of persons affected by mental illness and to advocate for their rights.
GAMIAN-Europe was established in 1998 as a representative coalition of patient organisations. Putting the patient at the centre of all issues of the EU healthcare debate, the organisation aims to bring together and support the development and policy influencing capacity of local, regional and national organisations active in the field of mental health.
GAMIAN Europe addresses the following topics:
Advocacy
Ø Act as the voice for patients, both at EU as well as at national level, and demonstrate that this voice is useful as well as indispensable
Ø Ensure that patients are at the centre of all aspects of healthcare provision
Ø Work to improve the availability, accessibility, and quality of treatment for all mental health problems
Information and education
Ø Improve the provision, reliability and quality of information on mental health problems for patients as well as the general public
Ø Assist in improving the training, education and understanding of mental illness of health and other professionals
Stigma and discrimination
Ø Increase awareness, knowledge and understanding of mental health problems
Ø Help reduce stigma, prejudice, and ignorance in relation to mental health problems and fight discrimination
Patients rights
Ø Focus on the development and enforcement of rights for persons affected by mental health problems, e.g. access to appropriate treatment
Cooperation, partnerships and capacity building
Ø Enable patient groups to collaborate with health professionals, policy makers, academics, and industryMain EU files targeted
Interest Group of MEP's on mental health, brain diseases and wellbeing
Address
Head Office
Rue du Trône 60
Brussels B1050
BELGIUM -
People
Total lobbyists declared
1
Employment time Lobbyists 25% 1 Lobbyists (Full time equivalent)
0.25
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 12 Apr 2017
Name Start date End Date Nigel OLISA 07 Nov 2023 06 Nov 2024 Diliana ANCORI 22 Feb 2024 21 Feb 2025 Karl LAVO 04 Nov 2023 31 Oct 2024 Ms Anastasia KAPODISTRIA 07 Nov 2023 06 Jan 2024 Ms Maria Cecilia ANGULO 07 Oct 2022 07 Oct 2023 Karl LAVO 07 Oct 2022 07 Oct 2023 Ms Cecilia ANGULO 07 Oct 2022 10 Nov 2022 Nigel OLISA 26 Apr 2022 26 Apr 2023 Ms Hilkka KARKKAINEN 27 Feb 2020 27 Feb 2021 Nigel OLISA 26 Feb 2020 26 Feb 2021 Mr Paul ARTEEL 28 Nov 2014 26 Nov 2015 Complementary Information
None declared
Person in charge of EU relations
Ms Christine Marking (Policy advisor)
Person with legal responsibility
Ms Hilkka Karkkainen (President)
-
Categories
Category
III - Non-governmental organisations
Subcategory
Non-governmental organisations, platforms and networks and similar
-
Networking
Affiliation
Member of International alliance of Patient Organisations - IAPO
Member of the European Patients Forum -EPF
Member of the European Brain Council - EBCMember organisations
None declared
-
Financial Data
Closed financial year
Jul 2015 - Jun 2016
Lobbying costs for closed financial year
9,999€
EU grant income for closed financial year
35,234 € (Source: research fp7)
Other financial info
None declared
-
EU Structures
Groups (European Commission)
None
ACC
None
Groups (European Parliament)
None
Communication activities
None
Other activities
In order to reach its objectives, GAMIAN-Europe
provides information and support to member organisations by means of educational seminars, conventions, a regular EU newsletter, handbooks on specific mental illnesses, and an up-to-date and accessible website.
facilitates an open and inclusive pan-European dialogue among patient organisations and other interested bodies to exchange information and ideas.
shares experience and examples of good practice to strengthen the role and voice of patient organisations and effective input in EU and national policy development.
forms active partnerships and cooperation with other stakeholders, e.g. the media, organisations (local, regional, national, European and academic institutions), employers and trade unions, the pharmaceutical industry, government and regulatory bodies and insurers with a view to
- securing the best possible treatment for patients with a mental illness and at the earliest possible opportunity
- supporting the development of health/mental health policies which take account of the views of patients
Meetings
Meetings
None declared